Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | TTR | P02766 | 3/20 | 0.56 |
| ▸ | HSPB1 | P04792 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.50 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.50 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7296262 | 0.87 | GPR35 (0.50) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL28069673 | 0.87 | MEN1 (0.57) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL29057897 | 0.84 | ALDH1A1 (0.54) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL29749853 | 0.84 | MEN1 (0.54) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL16333959 | 0.84 | MEN1 (0.54) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL29390372 | 0.82 | HSPB1 (0.73) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL708511 | 0.82 | ALDH1A1 (0.62) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL1042708 | 0.82 | HSPB1 (0.73) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL1191137 | 0.82 | HSD17B10 (0.56) | MEN1KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL18996628 | 0.82 | TDP1 (0.65) | MEN1KMT2AALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0633267-B1 | Process for the preparation of alpha-amino acid amide for use in peptide synthesis | SOLVAY (BE) | 2001-09-26 | — | — | EP | claimed |
| EP-0654043-A4 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN. | MALLINCKRODT MEDICAL INC (US) | 1997-07-16 | — | — | EP | claimed |
| US-5532171-A | PHENOTHIAZINE DYES FOR PHOTODYNAMIC THERAPY OF CANCER OR IMMUNOASSAY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-07-02 | — | — | US | claimed |
| US-5506362-A | Process for the preparation of an α-amino acid amide | SOLVAY (SOCIETE ANONYME) (BE) | 1996-04-09 | — | — | US | claimed |
| EP-0654043-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1995-05-24 | — | — | EP | claimed |
| WO-1994025488-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1994-11-10 | — | — | WO | claimed |
| US-5344928-A | Phenothiazine compounds for cancer treatment or immunoassay using chemiluminescence | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-06 | — | — | US | claimed |
| EP-0593452-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1994-04-27 | — | — | EP | claimed |
| EP-0540612-A1 | HETEROBIFUNCTIONAL REAGENTS AND CONJUGATES WITH OXAALKYLENE UNITS FOR AMPHIPHILIC BRIDGE STRUCTURES | Pharmacia AB (SE) | 1993-05-12 | — | — | EP | claimed |
| EP-0510668-A2 | Phenothiazine derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-10-28 | — | — | EP | claimed |
| EP-0593452-A4 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN. | MALLINCKRODT MEDICAL INC (US) | 1992-08-31 | — | — | EP | claimed |
| WO-1992001474-A1 | HETEROBIFUNCTIONAL REAGENTS AND CONJUGATES WITH OXAALKYLENE UNITS FOR AMPHIPHILIC BRIDGE STRUCTURES | KABI PHARMACIA AB (SE) | 1992-02-06 | — | — | WO | claimed |
| WO-1991007991-A1 | METHOD FOR PREPARING A METAL-RADIONUCLIDE-LABELLED PROTEIN | MALLINCKRODT MEDICAL, INC. (US) | 1991-06-13 | — | — | WO | claimed |
| EP-0362634-A2 | Basic dihydropyridines, process for their preparation and their use as intermediates | BAYER AG (DE) | 1990-04-11 | — | — | EP | claimed |
| EP-4387954-A1 | LONG-LIVED REDOX-ACTIVE MOLECULES WITH LOW REDOX POTENTIAL | President and Fellows of Harvard College (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240165267-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2024-05-23 | — | — | US | disclosed |
| US-11987590-B2 | Compounds that participate in cooperative binding and uses thereof | Revolution Medicines, Inc. (US) | 2024-05-21 | — | — | US | disclosed |
| US-4259350-A | PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK | SANKYO COMPANY LIMITED (JP) | 1981-03-31 | — | — | US | disclosed |
| EP-0000574-A1 | Benzimidazole-2 derivatives, their preparation and their use for the preparation of medicaments | CIBA-GEIGY AG (CH) | 1979-02-07 | — | — | EP | disclosed |
| US-3988326-A | Process for N-acylation of 7 amino cephem compounds | MEIJI SEIKA KAISHA, LTD. (JA) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11987590-B2 | Compounds that participate in cooperative binding and uses thereof | CEP170, PIN1, FKBP3 | MEN1 2531/4885KMT2A 4097/4885ALDH1A1 4800/4885 |
| US-20240165267-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | NSUN2, ADAR, NSUN3 | MEN1 2749/4885KMT2A 973/4885ALDH1A1 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.